# Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN)

> **NCT05388968** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 110 (estimated)

## Conditions studied

- Increased Nuchal Translucency in the First Trimester of Pregnancy

## Interventions

- **BIOLOGICAL:** Metatranscriptomic
- **DIAGNOSTIC_TEST:** Specific microbiologic diagnosis

## Key facts

- **NCT ID:** NCT05388968
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-07
- **Primary completion:** 2025-05
- **Final completion:** 2026-02
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05388968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05388968, "Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05388968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*